Results 1 to 10 of about 5,573 (260)

Patient Safety and Pro Re Nata Prescription and Administration: A Systematic Review [PDF]

Pharmacy (Basel, Switzerland), 2018
PRN is the acronym for ‘pro re nata,’ written against prescriptions whose administration should be based on patients’ needs, rather than at set times.
, Sara Amaniyan MScN, BScN, Sue Jordan
exaly   +10 more sources

The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the “Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)” project [PDF]

Annals of General Psychiatry, 2022
Background Several guidelines recommend monotherapy in pharmacotherapy for schizophrenia and major depressive disorder. The content of regular prescriptions has been reported in several studies, but not enough research has been conducted on the content ...
Yoshitaka Kyou, Norio Yasui-Furukori, Naomi Hasegawa, Kenta Ide, Kayo Ichihashi, Naoki Hashimoto, Hikaru Hori, Yoshihito Shimizu, Yayoi Imamura, Hiroyuki Muraoka, Hitoshi Iida, Kazutaka Ohi, Yuka Yasuda, Kazuyoshi Ogasawara, Shusuke Numata, Jun-ichi Iga, Takashi Tsuboi, Shinichiro Ochi, Fumitoshi Kodaka, Ryuji Furihata, Toshiaki Onitsuka, Manabu Makinodan, Hiroshi Komatsu, Masahiro Takeshima, Chika Kubota, Akitoyo Hishimoto, Kiyokazu Atake, Hirotaka Yamagata, Mikio Kido, Tatsuya Nagasawa, Masahide Usami, Taishiro Kishimoto, Saya Kikuchi, Junya Matsumoto, Kenichiro Miura, Hisashi Yamada, Koichiro Watanabe, Ken Inada, Ryota Hahimoto   +38 more
doaj   +4 more sources

Ten-year real-world outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration using pro re nata regimen [PDF]

BMJ Open Ophthalmology, 2023
Background/aims To analyse long-term outcomes of antivascular endothelial growth factor (anti-VEGF) therapy for the treatment of neovascular age-related macular degeneration (nAMD) using pro re nata (PRN) regimen in a single-centre clinical practice ...
Anja Tuulonen, Hannele Uusitalo-Järvinen, Heini Huhtala, Pekko Hujanen, Anu Vaajanen, Eemil Lehtonen, Ulla Syvänen, Heikki Ruha, Inka Pirinen   +8 more
doaj   +4 more sources

Treat-and-Extend vs. Pro Re Nata Regimen of Ranibizumab for Diabetic Macular Edema—A Two-Year Matched Comparative Study [PDF]

Frontiers in Medicine, 2022
PurposeTo compare 2-year treatment outcomes of ranibizumab using treat-and-extend (T&E) or pro re nata (PRN) regimens for diabetic macular edema (DME) in clinical settings.MethodsWe retrospectively enrolled 34 patients (34 eyes) with DME treated with
Tso-Ting Lai, Tso-Ting Lai, Ta-Ching Chen, Chang-Hao Yang, Chang-Hao Yang, Chung-May Yang, Chung-May Yang, Tzyy-Chang Ho, Yi-Ting Hsieh   +8 more
doaj   +4 more sources

Older Adults Living in Sheltered Housing’s Experiences of Involvement in Pro Re Nata Decisions. A Narrative Positioning Analysis [PDF]

Global Qualitative Nursing Research, 2021
Decisions regarding pro re nata medications might be challenging due to the complex nature of the practice. The aim of this study was to expand our understanding of the experiences of older people living in sheltered housings with regard to shared ...
Marianne Kollerøs Nilsen, Bodil H. Blix, Hege Sletvold, Rose Mari Olsen   +3 more
doaj   +4 more sources

Prevalence and types of medication errors in pro re nata medication orders among hospitalized patients: a cross-sectional study [PDF]

Journal of Pharmaceutical Health Care and Sciences
Background Medication errors in Pro Re Nata (PRN) prescriptions pose a significant threat in hospital settings, especially due to unclear prescribing practices.
Arefeh Rasouli-Rad, Mahdi Ahmadinia, Azadeh Eshraghi, Hamidreza Aslani, Zahra Karimian, Akram Hashemi, Maryam Farasatinasab   +6 more
doaj   +4 more sources

Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema [PDF]

GMS Ophthalmology Cases, 2020
Aims: To evaluate treatment outcomes of pro re nata dosing of intravitreal dexamethasone implant in eyes with refractory diabetic macular edema (DME) amongst Indian subjects.Methods and material: Retrospective, interventional case series. Medical records
Rishi, Pukhraj, Rishi, Ekta, Attiku, Yamini, Dhami, Abhinav, Iyer, Vandana   +4 more
doaj   +3 more sources

Pro Re Nata. [PDF]

J Grad Med Educ, 2020
Freedman-Weiss M.
europepmc   +5 more sources

Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen [PDF]

Journal of Ophthalmology, 2018
Purpose. To compare the qualitative and quantitative choroidal neovascularization (CNV) changes after antivascular endothelial growth factor (anti-VEGF) therapy in treatment-naïve and treated eyes with age-related macular degeneration (AMD) using optical
Alexandra Miere, Hassiba Oubraham, Francesca Amoroso, Pauline Butori, Polina Astroz, Oudy Semoun, Elsa Bruyere, Alexandre Pedinielli, Manar Addou-Regnard, Camille Jung, Salomon Y. Cohen, Eric H. Souied   +11 more
doaj   +4 more sources

‘To give or not to give medication, that is the question.’ Healthcare personnel’s perceptions of factors affecting pro re nata medication in sheltered housing for older adults — a focus-group interview study [PDF]

BMC Health Services Research, 2020
Background Residents living in sheltered housing depend on help from healthcare personnel (HCP) with medication management, regarding regular long-term and pro re nata (PRN) medication.
Marianne Kollerøs Nilsen, Hege Sletvold, Rose Mari Olsen   +2 more
doaj   +4 more sources